Boule Diagnostics swings to Q3 loss of SEK 2.5 million year over year

• Boule Diagnostics swung to a third-quarter loss of SEK 2.5 million from a year-earlier profit.
• Net sales fell 24% year over year to SEK 96.2 million, mainly due to weaker instrument business.
• Instrument volumes dropped 57% year over year to 363, due to component shortages and weak demand.
• Available cash, including unutilized overdraft facilities, declined 41% year over year to SEK 21.6 million at September 30.
• Financing remained unsecured, creating significant uncertainty over the going-concern assumption.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Boule Diagnostics AB published the original content used to generate this news brief on October 23, 2026, and is solely responsible for the information contained therein.